Privi Speciality Chemicals enterprise value

Share price at each year-end

Tap a line for its trend	Currentlast 12M	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus


12,703	—	—	—	—	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
161	97.7	57.3	63.5	27.2
27.3	28.2	14.5	16.7	6.4
1,010	1,010	1,123	981	1,061
13,579	—	—	—	—
849	912	1,065	917	1,033
₹3,476.32	—	—	—	—

2,612	2,451	2,241	1,922	1,896
38.7%	41.2%	50.1%	51.0%	55.9%
0.07×	—	—	—	—

4.93×	—	—	—	—
19.86×	—	—	—	—
25.28×	—	—	—	—
59.02×	—	—	—	—
2,753	2,564	2,101	1,752	1,608
684	646	454	325	186
537	502	322	202	77.4
—	550	281	354	48.8
230	230	−18.0	204	−90.9
—	208	−41.5	179	−112
—	320	299	151	140

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

PRIVISCL₹3,252.00

Privi Speciality Chemicals Ltd.

· Chemicals

₹ CrorePeersAARTIIND RAIN RALLIS RCF NFL REFEX NEOGEN LXCHEMMcap ₹12,703 Cr

HighlightsEnterprise Value Multiples Per ShareAnnuals · FY-end closes

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Current/LTM TTM · last close
Market Capitalization	—	—	—	—	12,703.2
- Cash, Equiv & ST Investments	27.2	63.5	57.3	97.7	161.0
+ Minority Interest	6.4	16.7	14.5	28.2	27.3
+ Total Debt	1,060.5	980.8	1,122.7	1,009.9	1,009.9
Enterprise Value	—	—	—	—	13,579.4
Net Debt (memo)	1,033.4	917.3	1,065.4	912.2	848.9
EV per Share	—	—	—	—	3,476.32

Total Capital	1,896.0	1,921.9	2,240.6	2,450.5	2,612.3
Total Debt/Total Capital	55.94	51.03	50.11	41.21	38.66
Total Debt/EV	—	—	—	—	0.07

EV/Sales	—	—	—	—	4.93
EV/EBITDA	—	—	—	—	19.86
EV/EBIT	—	—	—	—	25.28
EV/Free Cash Flow	—	—	—	—	59.02
Reference Items — Trailing FY Values
Sales	1,607.8	1,752.2	2,101.2	2,563.7	2,752.8
EBITDA	185.9	325.0	453.5	646.2	683.6
EBIT	77.4	201.5	321.8	502.4	537.2
Operating Cash Flow	48.8	354.5	281.1	550.1	—
Free Cash Flow	-90.9	204.0	-18.0	230.1	230.1
FCFF (free cash flow to the firm)	-111.9	178.8	-41.5	207.8	—
Capital Expenditure	139.7	150.5	299.1	320.0	—

Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.